Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McMaster University

$27,000.00

Efficacy and Safety of Treatments for IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis

FY 2025-26

Summary
Food allergies affect more than 3 million Canadians and about 1 in 2 households. Food allergies often begin in childhood, can last a lifetime, and can cause symptoms within minutes of eating even a tiny amount, including life-threatening anaphylaxis. Current management relies on guidelines published over a decade ago recommending strict avoidance of allergen foods and using epinephrine in emergencies, but newer options are being studied. For example, immunotherapy uses slowly increasing amounts of the allergen to reduce sensitivity, and biologics are medicines that block parts of the immune system to prevent reactions. Although some of these approaches help, they also increase harms such as allergic reactions and anaphylaxis. Patients, families, and clinicians are left with the same question: how effective and how safe are the available treatment options for food allergy? We will answer this by bringing together studies that have tested treatments for children with food allergy. We will look at how well each option works and how safe it is by combining the results of different trials, focusing on outcomes that patients and families have identified as important to them: allergic reactions (e.g. anaphylaxis), quality of life, whether children can safely eat more of the food without reacting (desensitization), whether this protection lasts even after stopping treatment (sustained unresponsiveness), and harms. We will create a clear, up-to-date summary of the benefits and harms of current and emerging treatments. These findings will directly inform a clinical practice guideline on food allergy, helping doctors and patients choose evidence-based treatments, answer questions that matter to patients and families, improve outcomes, and reduce the burden of food allergy.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573078
Name
Silang Isabella C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Efficacy and Safety of Treatments for IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Allergic Reactions; Biologics; Desensitization; Food Allergy Treatments; Ige-Mediated Food Allergy; Immunotherapy; Quality Of Life; Randomized Controlled Trials; Sustained Unresponsiveness; Systematic Review And Meta-Analysis
Abstract
Food allergies affect more than 3 million Canadians and about 1 in 2 households. Food allergies often begin in childhood, can last a lifetime, and can cause symptoms within minutes of eating even a tiny amount, including life-threatening anaphylaxis. Current management relies on guidelines published over a decade ago recommending strict avoidance of allergen foods and using epinephrine in emergencies, but newer options are being studied. For example, immunotherapy uses slowly increasing amounts of the allergen to reduce sensitivity, and biologics are medicines that block parts of the immune system to prevent reactions. Although some of these approaches help, they also increase harms such as allergic reactions and anaphylaxis. Patients, families, and clinicians are left with the same question: how effective and how safe are the available treatment options for food allergy? We will answer this by bringing together studies that have tested treatments for children with food allergy. We will look at how well each option works and how safe it is by combining the results of different trials, focusing on outcomes that patients and families have identified as important to them: allergic reactions (e.g. anaphylaxis), quality of life, whether children can safely eat more of the food without reacting (desensitization), whether this protection lasts even after stopping treatment (sustained unresponsiveness), and harms. We will create a clear, up-to-date summary of the benefits and harms of current and emerging treatments. These findings will directly inform a clinical practice guideline on food allergy, helping doctors and patients choose evidence-based treatments, answer questions that matter to patients and families, improve outcomes, and reduce the burden of food allergy.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silang, Isabella C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~